实施由护士提供的玻璃体内注射服务。
Implementation of a nurse-delivered intravitreal injection service.
作者信息
DaCosta J, Hamilton R, Nago J, Mapani A, Kennedy E, Luckett T, Pavesio C, Flanagan D
机构信息
Medical Retina Service, Moorfields Eye Hospital, London, UK.
出版信息
Eye (Lond). 2014 Jun;28(6):734-40. doi: 10.1038/eye.2014.69. Epub 2014 Apr 4.
Abstract
PURPOSE
The purpose of this study was to introduce nurse-delivered intravitreal injections to increase medical retina treatment capacity.
METHODS
Indemnity, clinical governance, training, planning, and implementation issues were addressed. The outcome measures were patient safety, patient experience, and clinic capacity.
RESULTS
No serious vision-threatening complications were recorded in a consecutive series of 4000 nurse-delivered intravitreal injections. A Mann-Whitney test showed a significant increase in intravitreal injections (P=0.003) in the medical retina service after introduction of nurse-delivered intravitreal injections. The majority of patients accepted and were satisfied with a nurse-delivered intravitreal injection.
DISCUSSION
Nurse-delivered intravitreal injections appear safe, acceptable to patients, and are an effective means to increase intravitreal injection capacity in medical retina clinics.
摘要
目的
本研究旨在引入由护士进行的玻璃体内注射，以提高医学视网膜疾病的治疗能力。
方法
探讨了赔偿、临床管理、培训、规划及实施等问题。结果指标包括患者安全性、患者体验及诊所治疗能力。
结果
在连续4000例由护士进行的玻璃体内注射中，未记录到严重的视力威胁性并发症。曼-惠特尼检验显示，引入由护士进行的玻璃体内注射后，医学视网膜服务中的玻璃体内注射量显著增加（P = 0.003）。大多数患者接受并满意由护士进行的玻璃体内注射。
讨论
由护士进行的玻璃体内注射似乎是安全的，患者可以接受，并且是提高医学视网膜诊所玻璃体内注射能力的有效手段。
相似文献
1
Implementation of a nurse-delivered intravitreal injection service.实施由护士提供的玻璃体内注射服务。
Eye (Lond). 2014 Jun;28(6):734-40. doi: 10.1038/eye.2014.69. Epub 2014 Apr 4.
2
Indemnity for orthoptist-delivered intravitreal injections.对由视光师进行的玻璃体内注射的赔偿。
Eye (Lond). 2015 Feb;29(2):290-1. doi: 10.1038/eye.2014.249. Epub 2014 Nov 21.
3
Utilisation of orthoptists to give intravitreal injections-a multidisciplinary approach.利用视光师进行玻璃体内注射——一种多学科方法。
Eye (Lond). 2015 Feb;29(2):290. doi: 10.1038/eye.2014.234. Epub 2014 Nov 21.
4
Nurse specialists for the administration of anti-vascular endothelial growth factor intravitreal injections.负责抗血管内皮生长因子玻璃体内注射给药的专科护士。
N Z Med J. 2016 Jul 15;129(1438):32-8.
5
Administration of repeat intravitreal anti-VEGF drugs by retina specialists in an injection-only clinic for patients with exudative AMD: patient acceptance and safety.
Semin Ophthalmol. 2011 Nov;26(6):380-6. doi: 10.3109/08820538.2011.622337.
6
Nurse-administered intravitreal injections: a systematic review.
Graefes Arch Clin Exp Ophthalmol. 2015 Sep;253(9):1619-21. doi: 10.1007/s00417-014-2921-y. Epub 2015 Jan 15.
7
Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy.反复玻璃体内注射抗血管内皮生长因子药物可能会增加新生血管性年龄相关性黄斑变性患者发生缺血性视神经病变的风险。
BMC Ophthalmol. 2019 Dec 30;19(1):268. doi: 10.1186/s12886-019-1284-x.
8
Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.用于治疗新生血管性年龄相关性黄斑变性的贝伐单抗持续给药方案：基线特征的重要性
Retina. 2014 May;34(5):846-52. doi: 10.1097/IAE.0000000000000033.
9
Task shifting of intraocular injections from physicians to nurses: a randomized single-masked noninferiority study.将眼内注射从医师转移到护士：一项随机单盲非劣效性研究。
Acta Ophthalmol. 2020 Mar;98(2):139-144. doi: 10.1111/aos.14184. Epub 2019 Jul 3.
10
Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.玻璃体内注射抗血管内皮生长因子治疗湿性年龄相关性黄斑变性：一项系统评价与Meta分析
Drug Des Devel Ther. 2015 Sep 28;9:5397-405. doi: 10.2147/DDDT.S86269. eCollection 2015.
引用本文的文献
1
Innovative care models: Expanding nurses' and optometrists' roles in ophthalmology.创新护理模式：扩大护士和验光师在眼科的作用。
Nurs Ethics. 2025 Sep;32(6):1900-1910. doi: 10.1177/09697330251317670. Epub 2025 Mar 12.
2
Board Certification Is Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections.玻璃体腔内注射后，获得委员会认证与眼内炎风险降低相关。
J Vitreoretin Dis. 2021 Aug 13;6(2):116-121. doi: 10.1177/24741264211028519. eCollection 2022 Mar-Apr.
3
Cost consequences of task-shifting intravitreal injections from physicians to nurses in a tertiary hospital in Norway.将玻璃体腔内注射从医生转移到挪威一家三级医院的护士手中的成本后果。
BMC Health Serv Res. 2023 Mar 8;23(1):229. doi: 10.1186/s12913-023-09186-0.
4
Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes.英国糖尿病性黄斑水肿患者标准护理玻璃体内阿柏西普治疗实践评估：DRAKO 研究结果。
Eye (Lond). 2023 Aug;37(12):2527-2534. doi: 10.1038/s41433-022-02367-x. Epub 2023 Jan 18.
5
Task shifting of intravitreal injections from physicians to nurses: a qualitative study.将玻璃体腔内注射从医生转移到护士：一项定性研究。
BMC Health Serv Res. 2021 Oct 30;21(1):1185. doi: 10.1186/s12913-021-07203-8.
6
Capacity building in screening and treatment of diabetic retinopathy in Asia-Pacific region.亚太地区糖尿病视网膜病变筛查和治疗能力建设。
Indian J Ophthalmol. 2021 Nov;69(11):2959-2967. doi: 10.4103/ijo.IJO_1075_21.
7
Situational analysis of diabetic retinopathy treatment Services in Ghana.加纳糖尿病视网膜病变治疗服务的情境分析。
BMC Health Serv Res. 2021 Jun 17;21(1):584. doi: 10.1186/s12913-021-06608-9.
8
A Comparison of Conventional Intravitreal Injection Method vs InVitria Intravitreal Injection Method.传统玻璃体内注射法与InVitria玻璃体内注射法的比较。
Clin Ophthalmol. 2020 Aug 27;14:2507-2513. doi: 10.2147/OPTH.S238529. eCollection 2020.
9
Eliminating Visual Acuity and Dilated Fundus Examinations Improves Cost Efficiency of Performing Optical Coherence Tomogrpahy-Guided Intravitreal Injections.消除视力和眼底散瞳检查可提高光相干断层扫描引导下玻璃体腔内注射的成本效率。
Am J Ophthalmol. 2020 Nov;219:222-230. doi: 10.1016/j.ajo.2020.06.028. Epub 2020 Jul 2.
10
Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service Delivery.提供安全有效的玻璃体内治疗服务：服务提供策略
Clin Ophthalmol. 2020 May 15;14:1315-1328. doi: 10.2147/OPTH.S233061. eCollection 2020.
本文引用的文献
1
Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.英国眼内抗血管内皮生长因子内眼炎：发病率、特征、风险因素和结局。
Eye (Lond). 2012 Dec;26(12):1517-26. doi: 10.1038/eye.2012.199. Epub 2012 Oct 12.
2
The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200,000 practitioners.全球执业和培训中的眼科医生人数：尽管有超过 20 万名从业者，但差距仍在扩大。
Br J Ophthalmol. 2012 Jun;96(6):783-7. doi: 10.1136/bjophthalmol-2011-301378. Epub 2012 Mar 26.
3
Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy.模型预测英国年龄相关性黄斑变性（2010-2020 年）的流行情况：抗血管内皮生长因子（VEGF）治疗的预期影响。
Br J Ophthalmol. 2011 Oct;95(10):1433-6. doi: 10.1136/bjo.2010.195370. Epub 2011 Feb 12.
4
Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).欧洲老年人年龄相关性黄斑病变的患病率：欧洲眼研究（EUREYE）
Arch Ophthalmol. 2006 Apr;124(4):529-35. doi: 10.1001/archopht.124.4.529.
5
Leading causes of certification for blindness and partial sight in England & Wales.英格兰和威尔士失明及视力部分丧失认证的主要原因。
BMC Public Health. 2006 Mar 8;6:58. doi: 10.1186/1471-2458-6-58.
6
Primary care and ophthalmology in the United Kingdom.英国的初级医疗保健与眼科
Br J Ophthalmol. 2003 Apr;87(4):493-9. doi: 10.1136/bjo.87.4.493.
7
Shared care, past and future.
Ophthalmic Physiol Opt. 1995 Sep;15(5):379-81.
Zotero 插件